High Dose Rate Brachytherapy + intra-lesional boost IMRT for carcinoma, squamous cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Feb 2025: Trial started, NCT07435376
  2. 27 Feb 2026: Trial registered, NCT07435376

The trials

NCT07435376: Intra-lesional Tumor Boost for Bulky Cervical Cancer

State
Under way
Phase
Phase 2
People
17 planned
Started
23 Feb 2025
Primary completion
30 Sep 2026
Arms
Intra-lesional Boost Group
Results
None posted
  1. 23 Feb 2025: Trial started
  2. 27 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.